State Street’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $32.8B | Buy |
35,610,002
+248,086
| +0.7% | +$252M | 1.13% | 13 |
|
|
2025
Q4 | $38B | Buy |
35,361,916
+635,358
| +2% | +$608M | 1.27% | 11 |
|
|
2025
Q3 | $26.5B | Buy |
34,726,558
+219,590
| +0.6% | +$163M | 0.92% | 13 |
|
|
2025
Q2 | $26.9B | Buy |
34,506,968
+69,018
| +0.2% | +$53.6M | 1.01% | 13 |
|
|
2025
Q1 | $28.4B | Buy |
34,437,950
+124,043
| +0.4% | +$103M | 1.17% | 13 |
|
|
2024
Q4 | $26.5B | Buy |
34,313,907
+461,692
| +1% | +$382M | 1.05% | 12 |
|
|
2024
Q3 | $30B | Sell |
33,852,215
-25,347
| -0.1% | -$22.8M | 1.22% | 10 |
|
|
2024
Q2 | $30.7B | Sell |
33,877,562
-381,004
| -1% | -$305M | 1.34% | 8 |
|
|
2024
Q1 | $26.7B | Buy |
34,258,566
+471,239
| +1% | +$335M | 1.19% | 9 |
|
|
2023
Q4 | $19.7B | Buy |
33,787,327
+380,469
| +1% | +$222M | 0.96% | 15 |
|
|
2023
Q3 | $17.9B | Sell |
33,406,858
-471,559
| -1% | -$243M | 1% | 14 |
|
|
2023
Q2 | $15.9B | Buy |
33,878,417
+642,274
| +2% | +$269M | 0.83% | 17 |
|
|
2023
Q1 | $11.4B | Sell |
33,236,143
-478,944
| -1% | -$162M | 0.64% | 24 |
|
|
2022
Q4 | $12.3B | Buy |
33,715,087
+132,615
| +0.4% | +$47M | 0.72% | 21 |
|
|
2022
Q3 | $10.9B | Buy |
33,582,472
+168,444
| +0.5% | +$53.4M | 0.69% | 20 |
|
|
2022
Q2 | $10.8B | Sell |
33,414,028
-339,894
| -1% | -$102M | 0.65% | 22 |
|
|
2022
Q1 | $9.67B | Sell |
33,753,922
-175,942
| -0.5% | -$45.3M | 0.48% | 32 |
|
|
2021
Q4 | $9.37B | Buy |
33,929,864
+813,983
| +2% | +$206M | 0.44% | 39 |
|
|
2021
Q3 | $7.65B | Buy |
33,115,881
+188,305
| +0.6% | +$46.5M | 0.4% | 51 |
|
|
2021
Q2 | $7.56B | Buy |
32,927,576
+421,475
| +1% | +$84.7M | 0.4% | 50 |
|
|
2021
Q1 | $6.07B | Sell |
32,506,101
-962,779
| -3% | -$188M | 0.35% | 61 |
|
|
2020
Q4 | $5.65B | Sell |
33,468,880
-1,466,238
| -4% | -$219M | 0.35% | 58 |
|
|
2020
Q3 | $5.17B | Sell |
34,935,118
-1,762,927
| -5% | -$273M | 0.35% | 60 |
|
|
2020
Q2 | $6.03B | Sell |
36,698,045
-353,117
| -1% | -$54.2M | 0.44% | 44 |
|
|
2020
Q1 | $5.14B | Sell |
37,051,162
-115,603
| -0.3% | -$15.9M | 0.45% | 46 |
|
|
2019
Q4 | $4.88B | Buy |
37,166,765
+56,350
| +0.2% | +$6.53M | 0.33% | 63 |
|
|
2019
Q3 | $4.15B | Sell |
37,110,415
-632,137
| -2% | -$70.4M | 0.31% | 66 |
|
|
2019
Q2 | $4.18B | Sell |
37,742,552
-449,691
| -1% | -$53M | 0.31% | 64 |
|
|
2019
Q1 | $4.96B | Sell |
38,192,243
-1,379,523
| -3% | -$168M | 0.39% | 51 |
|
|
2018
Q4 | $4.58B | Sell |
39,571,766
-442,845
| -1% | -$49.5M | 0.42% | 45 |
|
|
2018
Q3 | $4.29B | Buy |
40,014,611
+940,949
| +2% | +$94.1M | 0.33% | 59 |
|
|
2018
Q2 | $3.33B | Sell |
39,073,662
-444,163
| -1% | -$36.5M | 0.28% | 75 |
|
|
2018
Q1 | $3.06B | Sell |
39,517,825
-1,732,366
| -4% | -$139M | 0.26% | 77 |
|
|
2017
Q4 | $3.48B | Buy |
41,250,191
+27,331
| +0.1% | +$2.33M | 0.28% | 67 |
|
|
2017
Q3 | $3.53B | Sell |
41,222,860
-751,157
| -2% | -$61.6M | 0.3% | 63 |
|
|
2017
Q2 | $3.45B | Sell |
41,974,017
-389,918
| -0.9% | -$31.8M | 0.31% | 63 |
|
|
2017
Q1 | $3.56B | Buy |
42,363,935
+651,424
| +2% | +$52.2M | 0.32% | 60 |
|
|
2016
Q4 | $3.07B | Buy |
41,712,511
+1,945,594
| +5% | +$145M | 0.29% | 66 |
|
|
2016
Q3 | $3.19B | Buy |
39,766,917
+997,309
| +3% | +$79.8M | 0.32% | 60 |
|
|
2016
Q2 | $3.05B | Sell |
38,769,608
-219,669
| -0.6% | -$16.5M | 0.33% | 60 |
|
|
2016
Q1 | $2.81B | Sell |
38,989,277
-516,662
| -1% | -$39.1M | 0.3% | 64 |
|
|
2015
Q4 | $3.33B | Sell |
39,505,939
-899
| -0% | -$74.6K | 0.36% | 59 |
|
|
2015
Q3 | $3.31B | Sell |
39,506,838
-614,194
| -2% | -$51.9M | 0.38% | 56 |
|
|
2015
Q2 | $3.35B | Sell |
40,121,032
-2,234,966
| -5% | -$170M | 0.36% | 57 |
|
|
2015
Q1 | $3.08B | Sell |
42,355,998
-2,827,683
| -6% | -$201M | 0.32% | 67 |
|
|
2014
Q4 | $3.12B | Buy |
45,183,681
+651,457
| +1% | +$44M | 0.31% | 68 |
|
|
2014
Q3 | $2.89B | Buy |
44,532,224
+602,042
| +1% | +$38.1M | 0.31% | 64 |
|
|
2014
Q2 | $2.73B | Buy |
43,930,182
+1,507,816
| +4% | +$90M | 0.29% | 71 |
|
|
2014
Q1 | $2.5B | Sell |
42,422,366
-1,619,547
| -4% | -$90.4M | 0.28% | 71 |
|
|
2013
Q4 | $2.25B | Buy |
44,041,913
+1,583,949
| +4% | +$79.3M | 0.25% | 82 |
|
|
2013
Q3 | $2.14B | Sell |
42,457,964
-958,593
| -2% | -$50.2M | 0.26% | 80 |
|
|
2013
Q2 | $2.13B | Buy |
+43,416,557
| New | +$2.36B | 0.28% | 71 |
|
Other funds holding LLY
VCM
VPM
State Street's LLY Position: Q1 2026 in Review
State Street increased its Eli Lilly (LLY) stake by 0.7% in Q1 2026, buying an estimated $252M and bringing the position to 35,610,002 shares worth $32.8B. The position accounts for 1.13% of the portfolio, ranked #13.
State Street first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $38B in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- State Street held 35,610,002 shares of Eli Lilly worth $32.8B as of Q1 2026.
- State Street bought 248,086 Eli Lilly shares in Q1 2026, an estimated $252M.
- Eli Lilly made up 1.13% of State Street's portfolio in Q1 2026, its #13 holding.
- State Street first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- State Street's Eli Lilly position peaked at $38B in Q4 2025.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.